Impel Neuropharma Acute Migraine Treatment
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…
The Trump Administration announced on November 23 about launching a new prescription drug model, to lover price on medicine. HHS (The U.S. Department of Health…
On November 20, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the…
On November 10 SingleCare company announced a new delivery service. SingleCare is a free prescription savings service, their new delivery service promice to the customers…
On Friday, November 6, The FDA (U.S. Food and Drug Administration) reported about efforts of protecting patients from exposure to poor quality compounded drugs by…
The FDA (U. S. Food and Drug Administration) announced on October 27, about new approved lotion for nonprescription, or over-the-counter (OTC), use through a process…
On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…
Recently Bonum Health announced about their partnership with Singlecare, for prescription saving. On October 13, Trxade Group Inc., an integrated drug procurement, delivery and healthcare…
On October 8th, Walgreens drugstore chain announced, Find Rx Coverage Advisor to support patients in maintaining affordable access to medications as health insurance shifts for…
Acella Pharmaceuticals, LLC recalls recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to…